AI Spots Breast Cancer Signs 6 Years Before Diagnosis — Jun 12, 2026
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
An AI just spotted breast cancer in scans taken six years before diagnosis.
Run time: 20:02
In today's episode:
- AI sees breast cancer six years before diagnosis
- Stanford crowd cooled on AI scribes after debate
- Most clinicians admit using unapproved AI tools
- Saudi hospital shows off practical AI at HLTH Europe
- States move to regulate AI in insurance approvals
- Stanford and Mayo read tumors from a blood draw
- Anthropic splits subscription and API credits June 15
- xAI's Grok V9 lands mid-June, built on Cursor data
- Gemini 3.5 Pro still waiting on its June release
TL;DR:
- A Radiology study found three FDA-cleared mammography AIs flagged signs of breast cancer up to six years before diagnosis in about one in five cancers — retrospective, but a big, clean dataset.
- The honest counter-current: Stanford clinicians' support for AI scribes dropped from 69% to 54% after a live debate, and a new survey says ~72% of healthcare staff reach for unapproved "shadow AI" when sanctioned tools fall short.
- Anthropic is splitting subscription and programmatic usage into separate credit pools on June 15 and retiring Opus 4.1 on August 5 — plan your pipelines now.
Sources cited:
- EurekAlert / Radiology
- Stanford Medicine
- Wolters Kluwer
- GlobeNewswire
- Transparency Coalition
- Releasebot
- TechTimes
- TechTimes
Subscribe: YouTube
medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません